Notice of Intent to Sole Source – PREVENTIONGENETICS LLC – laboratory genetic testing services

Where this opportunity stands

Every notice posted under solicitation NOI-OD-26-008338 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Answer the notice: this is when the requirement can still be shaped.
• Contact the contracting officer named on the notice.
• Check who won similar work; they are the likely bidders.

Who won similar work

11 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) Q301.

Single-winner award sizes (11): middle half $70K to $297K, median $157K; range $27K to $35.0M.

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Sep 29, 2026THE BROAD INSTITUTE, INC$215KWhole genome sequencing for investigation of age-related chronic disease in HANDLS participantsNo listed company matched (Materiality N/A)
• Sep 26, 2025BAYLOR MIRACA GENETICS LABORATORIES LLC$232KQ--Clinical TestingNo listed company matched (Materiality N/A)
• Sep 25, 2025GREENWOOD GENETIC CENTER INC$49KQ--Genetic Testing with Greenwood Genetic Center IncNo listed company matched (Materiality N/A)
• Sep 23, 2025NEW YORK STEM CELL FOUNDATION INC$362KQ--iPSC Generation and Beta Cell DifferentiationNo listed company matched (Materiality N/A)
• Sep 22, 2025KAISER FOUNDATION HOSPITALS 1 KAISER PLAZA 22ND FLOOR Oakland CA 94612 USA$115KQ--Adherence with continuous positive airwayNo listed company matched (Materiality N/A)
• Sep 19, 2025NORGEN BIOTEK CORP$157KQ--Small RNA characterization of urinary exosomesNo listed company matched (Materiality N/A)
• Sep 19, 2025ProteinTech Group Inc$90KCRO Services for Single-Cell Multiomics ProfilingNo listed company matched (Materiality N/A)
• Jul 24, 2025ADVANCED CELL DIAGNOSTICS, INC.$27KQ--RNAscope In-House AssayMateriality: <0.01% of $TECH revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). For this company the latest 10-K year is used. Here: $27K award ÷ $1.2B revenue, fiscal year ending Jun 30, 2026 (SEC 10-K). SEC
• May 5, 2025HISTOSERV, INC$29KSignatures of aging outcomesNo listed company matched (Materiality N/A)
• Dec 31, 2024PSOMAGEN INC$533KLong read sequencing servicesNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.